Therapeutic Efficacy Study of Pyrimethamine/Sulfdoxine (Fansidar®) for the Treatment of Uncomplicated Falciparum Malaria in the Peruvian Amazon
NACompletedINTERVENTIONAL
Timeline
Start Date
January 31, 1998
Primary Completion Date
June 30, 1999
Study Completion Date
August 31, 2009
Conditions
Malaria, VivaxMalaria, Falciparum
Interventions
DRUG
Pyrimethamine/sulfdoxine (Fansidar)
Trial Locations (1)
Unknown
Naval Medical Research Center Detachment, Lima
All Listed Sponsors
lead
Walter Reed Army Institute of Research (WRAIR)
FED
NCT00951106 - Therapeutic Efficacy Study of Pyrimethamine/Sulfdoxine (Fansidar®) for the Treatment of Uncomplicated Falciparum Malaria in the Peruvian Amazon | Biotech Hunter | Biotech Hunter